This paper dives into how nanotechnology is chang-ing the game in medicine and healthcare. By working with materials at the nanoscale – that’s one-billionth of a meter – scientists can tweak physical, chemical, and biological properties in ways that are really different from larger materials. The study takes an interdisciplinary approach, pulling together data from research articles, clinical trials, and case studies since 2010 to showcase the latest in nanomedicine, biotechnology, and genetic engineering. Key findings show that nanotech is fantastic for improving diagnostic accuracy, allowing for early detection of diseases at the cellular and molecular level. When it comes to treatment, the paper talks about how engineered nanoparticles can really enhance drug delivery systems, making medications more soluble, stable, and effective while reducing side effects through targeted delivery. For example, using magnetic drug delivery and specialized nanoparticles in cancer treatment can directly target tumors and help with neurological issues, but there are still some challenges with non-specific accumulation and potential toxicity. The paper also looks into exciting areas like regenerative medicine, monitoring health in real-time with nanosensors, and the possible creation of nanorobots for targeted cell destruction. Even though there’s a lot of promise, the study points out some major roadblocks for getting these technologies into clinical use, like concerns over biocompatibility, the ability to scale up manufacturing, and the strict regulatory hoops they need to jump through. In short, while nanotechnology has incredible potential to change personalized medicine and disease prevention, ongoing research across different fields is crucial to tackle the current technical and safety hurdles.

Index Terms—nanotechnology, nanomedicine, drug-delivery, diagnostics, healthcare, regenerative medicine